Mechanisms of Altered Ventilatory Control in Heart Failure

NCT ID: NCT02421341

Last Updated: 2021-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2019-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done because the investigators are trying to understand how feedback from the muscles can influence your blood pressure and breathing during exercise, and if the investigators can reduce this response in heart failure patients. The investigators are also trying to determine ways to improve tolerance to exercise in heart failure patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

If you are enrolled in this study the investigators will ask you to make 3 separate study visits.

During study visit 1 you will be asked to get a blood draw, DEXA bone scan, perform pulmonary function tests, and exercise on a stationary bike at maximal exertion while breathing into a mouth piece.

During study visits 2 and 3 you will be asked to again exercise at maximal exertion while breathing into a mouth piece. However, during these two visits you will be receiving an intrathecal injection of fentanyl one day and placebo the other day, randomly selected and you will be blinded as to which you are receiving. A catheter will also be placed in an artery in your arm and a vein in your leg, which will help us to measure blood flow, blood pressure and draw blood when need be. The investigators will also ask you to perform a brief chemosensitivity test, breathing in and out your own air, after you are done exercising.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Heart, Cardiovascular Pulmonary Skeletal Muscle Exercise

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Drug - Fentanyl

Study visit 1 you will be asked to get a blood draw, DEXA bone scan, perform pulmonary function tests, and exercise on a stationary bike at maximal exertion while breathing into a mouth piece. Study visits 2 and 3 you will be asked to again exercise at maximal exertion while breathing into a mouth piece. During these two visits you will be receiving an intrathecal injection of either fentanyl or placebo, randomly selected and you will be blinded as to which you are receiving. Catheters will also be placed in an artery in your arm and a vein in your leg, helping us to measure blood flow, blood pressure and draw blood. You will also perform a chemosensitivity test, breathing in and out your own air, after you are done exercising.

Group Type EXPERIMENTAL

Fentanyl

Intervention Type DRUG

During study visits 2 and 3 you will receive an intrathecal (fluid filled space surrounding the spinal cord) injection of either fentanyl or placebo (saline). Fentanyl is an opiate (narcotic) drug and a common medication, however the way fentanyl is being used in this study is considered investigational.

Catheters

Intervention Type PROCEDURE

A catheter (small plastic tube placed in a blood vessel) will be placed in an artery in your arm and a second catheter will be placed in a vein in your leg. Local anesthetic will be used to minimize discomfort. These catheters will allow us to measure blood pressure, leg blood flow and draw blood.

Exercise

Intervention Type OTHER

You will be asked to exercise, ride a stationary bike, at maximal exertion.

DEXA

Intervention Type RADIATION

During study visit one you will have a DEXA scan. This procedure requires you to lie on a table while a small x-ray tube passes under your body.

Pulmonary Function Tests

Intervention Type OTHER

During study visit one you will be asked to perform 5 different breathing tests to help us better understand your lung function.

Blood Draw

Intervention Type OTHER

You will have approximately 350 mls (1.25 cups) of blood drawn during the duration of this study.

Chemosensitivity Test

Intervention Type OTHER

Using a bag you breath in and out your own air.

Placebo

Study visit 1 you will be asked to get a blood draw, DEXA bone scan, perform pulmonary function tests, and exercise on a stationary bike at maximal exertion while breathing into a mouth piece. Study visits 2 and 3 you will be asked to again exercise at maximal exertion while breathing into a mouth piece. During these two visits you will be receiving an intrathecal injection of either fentanyl or placebo, randomly selected and you will be blinded as to which you are receiving. Catheters will also be placed in an artery in your arm and a vein in your leg, helping us to measure blood flow, blood pressure and draw blood. You will also perform a chemosensitivity test, breathing in and out your own air, after you are done exercising.

Group Type PLACEBO_COMPARATOR

Catheters

Intervention Type PROCEDURE

A catheter (small plastic tube placed in a blood vessel) will be placed in an artery in your arm and a second catheter will be placed in a vein in your leg. Local anesthetic will be used to minimize discomfort. These catheters will allow us to measure blood pressure, leg blood flow and draw blood.

Exercise

Intervention Type OTHER

You will be asked to exercise, ride a stationary bike, at maximal exertion.

DEXA

Intervention Type RADIATION

During study visit one you will have a DEXA scan. This procedure requires you to lie on a table while a small x-ray tube passes under your body.

Pulmonary Function Tests

Intervention Type OTHER

During study visit one you will be asked to perform 5 different breathing tests to help us better understand your lung function.

Blood Draw

Intervention Type OTHER

You will have approximately 350 mls (1.25 cups) of blood drawn during the duration of this study.

Chemosensitivity Test

Intervention Type OTHER

Using a bag you breath in and out your own air.

Placebo

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fentanyl

During study visits 2 and 3 you will receive an intrathecal (fluid filled space surrounding the spinal cord) injection of either fentanyl or placebo (saline). Fentanyl is an opiate (narcotic) drug and a common medication, however the way fentanyl is being used in this study is considered investigational.

Intervention Type DRUG

Catheters

A catheter (small plastic tube placed in a blood vessel) will be placed in an artery in your arm and a second catheter will be placed in a vein in your leg. Local anesthetic will be used to minimize discomfort. These catheters will allow us to measure blood pressure, leg blood flow and draw blood.

Intervention Type PROCEDURE

Exercise

You will be asked to exercise, ride a stationary bike, at maximal exertion.

Intervention Type OTHER

DEXA

During study visit one you will have a DEXA scan. This procedure requires you to lie on a table while a small x-ray tube passes under your body.

Intervention Type RADIATION

Pulmonary Function Tests

During study visit one you will be asked to perform 5 different breathing tests to help us better understand your lung function.

Intervention Type OTHER

Blood Draw

You will have approximately 350 mls (1.25 cups) of blood drawn during the duration of this study.

Intervention Type OTHER

Chemosensitivity Test

Using a bag you breath in and out your own air.

Intervention Type OTHER

Placebo

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Analgesic, Opioid

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* History of ischemic or idiopathic dilated cardiomyopathy
* New York Heart Association class 1-3
* No history of dangerous arrhythmia's
* Not pacemaker dependent
* Body Mass Index less than or equal to 35 kg/m
* Current non-smokers with less than 15 pack year history
* Non-pregnant women
* Individuals who are able to exercise without orthopedic limitations

Exclusion Criteria

Control Participants:

* Will be matched for age, gender, height and weight and will have no history of cardiovascular related abnormalities.
* Body Mass Index less than 35 kg/m
* Current non-smokers with less than 15 pack year history
* Non-pregnant women
* Individuals who are able to exercise without orthopedic limitations
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas P. Olson, M.S., Ph.D.

PI

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Olson, PhD

Role: PRINCIPAL_INVESTIGATOR

Mayo Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic - Saint Marys Hospital

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

12-005318

Identifier Type: -

Identifier Source: org_study_id